Journals should develop guidelines for economic evaluationsBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6976.402a (Published 11 February 1995) Cite this as: BMJ 1995;310:402
- Martin E Backhouse
- Head of health economics SmithKline Beecham Pharmaceuticals, Welwyn Garden City AL7 1EY
EDITOR,—The cost-benefit analysis of travel prophylaxis reported by R H Behrens and J A Roberts is flawed.1 Among other things, such an analysis requires a monetary value to be placed on all the benefits resulting from a health care intervention.2 The …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial